Lab Med Online.  2020 Jul;10(3):242-246. 10.3343/lmo.2020.10.3.242.

Inhibition of Cross-Reactive Carbohydrate Determinant–Specific IgEs Reduce False Positive Reponses to Multiple Allergen Simultaneous Test–Immunoblot Assay: A Case Study

• Song DY
• Lee JH
• Kim SM
• Jun SH
• Lee K
• Song SH
• Song J

• KMID: 2504135
• DOI: http://doi.org/10.3343/lmo.2020.10.3.242

Abstract

Cross-reactive carbohydrate determinants (CCDs) are simple carbohydrates linked to amino acid chains; they are found in pollens, vegetable foods, insect, and Hymenoptera venoms and are broadly cross-reactive with CCD-specific IgE antibodies. A man in his fifties was evaluated using a multiple allergen simultaneous test–immunoblot assay. On the PROTIA Allergy-Q 64 inhalant panel (ProteomeTech, Korea), reactions to 37 of 59 antigens were observed except mammalian antigens, and cross-reactivity owing to anti-CCD antibodies was suspected. After ProGlycAn CCD-blocker (ProGlycAn, Austria) treatment, the patient exhibited no response to CCD allergens, and the number of allergens showing positive reactions was reduced to 15. We further tested a total of 7 samples from patients who were suspected to have CCD-related cross-reactivity. For these 8 patients, the average number of positive reactions to allergens was reduced from 33 (range 24-36) to 8 (range 0-19) after CCD-blocker treatment. We concluded that CCD-blocker treatment in sample with anti-CCD antibodies can reduce the false positive reponse and provide more specific information about allergens.

Keyword

Cross-reactive carbohydrates; Cross-reactive carbohydrate determinats; Allergens; Epitopes; False positives; IgE

Figure

• 

  Fig. 1 Prototypical structure of cross-reactive carbohydrate determinant.

Reference

1. Steiss JO, Strohner P, Zimmer KP, Lindemann H. 2008; Reduction of the total IgE level by omalizumab in children and adolescents. J Asthma. 45:233–6. DOI: 10.1080/02770900701883782. PMID: 18415832.

2. Kim M, Kim EK, Lee J, Park J, Kim T. 2018; Understanding of allergen-specific IgE test. Korean J Med. 93:452–6. DOI: 10.3904/kjm.2018.93.5.452.

3. Grzywnowicz M, Majsiak E, Gawel J, Miśkiewicz K, Doniec Z, Kurzawa R. 2018; Inhibition of cross-reactive carbohydrate determinants in allergy diagnostics. Adv Exp Med Biol. 1116:75–9. DOI: 10.1007/5584_2018_266. PMID: 30242787.

4. Altmann F. 2016; Coping with cross-reactive carbohydrate determinants in allergy diagnosis. Allergo J Int. 25:98–105. DOI: 10.1007/s40629-016-0115-3. PMID: 27656353. PMCID: PMC5016538.

5. van Ree R. 2002; Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol. 129:189–97. DOI: 10.1159/000066770. PMID: 12444315.

6. Altmann F. 2007; The role of protein glycosylation in allergy. Int Arch Allergy Immunol. 142:99–115. DOI: 10.1159/000096114. PMID: 17033195.

7. Altmann F. 2010; Basophil activation test is better but not good enough for the diagnosis of hymenoptera venom allergy: the problem of cross-reactive carbohydrate determinants. Clin Exp Allergy. 40:1290–2. DOI: 10.1111/j.1365-2222.2010.03569.x. PMID: 20701613.

8. Bennich HH, Ishizaka K, Johansson S, Rowe DS, Stanworth DB, Terry WD. 1968; Immunoglobulin E: a new class of human immunoglobulin. Immunology. 15:323–4. PMID: 4176102. PMCID: PMC1409482.

9. Pipkorn U. 1988; Pharmacological in uence of antiallergic medication on in vivo allergen testing. Allergy. 43:81–6. DOI: 10.1111/j.1398-9995.1988.tb00398.x. PMID: 2896467.

10. Chung HL. 2007; Clinical significance of serum IgE. Korean J Pediatr. 50:416–21. DOI: 10.3345/kjp.2007.50.5.416.

11. Mari A. 2002; IgE to cross-reactive carbohydrate determinants: analysis of the distribution and appraisal of the in vivo and in vitro reactivity. Int Arch Allergy Immunol. 129:286–95. DOI: 10.1159/000067591. PMID: 12483033.

12. Kim YS, Kim Y. 2007; Research on allergy-causing materials of allergy diseases. Korean J Clin Lab Sci. 39:201–9.

13. Yokoi H, Yoshitake H, Matsumoto Y, Kawada M, Takato Y, Shinagawa K, et al. 2017; Involvement of cross-reactive carbohydrate determinants-specific IgE in pollen allergy testing. Asia Pac Allergy. 7:29–36. DOI: 10.5415/apallergy.2017.7.1.29. PMID: 28154803. PMCID: PMC5287067.

14. Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude Elberink J. EAACI Interest Group on Insect Venom Hypersensitivity. 2005; Diagnosis of Hymenoptera venom allergy. Allergy. 60:1339–49. DOI: 10.1111/j.1398-9995.2005.00963.x. PMID: 16197464.